CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,082)	$ (44,374)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	27,762	41,164
Non-cash operating lease costs	20,669	19,476
Stock-based compensation	39,700	45,131
Amortization of discount and debt issue costs	506	844
Gain on remeasurement of contingent consideration	0	(1,960)
Other, net	753	191
Change in operating assets and liabilities, net of businesses acquired:
Patient accounts receivable, net	2,318	(41,815)
Prepaid expenses and other current assets	(15,179)	(2,762)
Accounts payable	(277)	3,208
Accrued payroll expenses	11,725	20,100
Operating lease liabilities	(23,498)	(22,082)
Other accrued expenses	(93)	5,101
Net cash provided by operating activities	61,304	22,222
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(14,923)	(10,214)
Net cash used in investing activities	(14,923)	(10,214)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments of long-term debt	(3,625)	(1,463)
Payments of contingent consideration	0	(2,400)
Taxes related to net share settlement of equity awards	(8,398)	0
Net cash used in financing activities	(12,023)	(3,863)
NET INCREASE IN CASH AND CASH EQUIVALENTS	34,358	8,145
Cash and Cash Equivalents - Beginning of period	154,571	78,824
CASH AND CASH EQUIVALENTS – END OF PERIOD	188,929	86,969
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest, net	8,753	12,626
Cash paid for taxes, net of refunds	1,459	(154)
SUPPLEMENTAL DISCLOSURES OF NON CASH INVESTING AND FINANCING ACTIVITIES
Acquisition of property and equipment included in liabilities	$ 2,286	$ 1,726